NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. ONON
6. BA
7. RTB
8. AAPL
9. FFAI
10. TRMD

Go back to NeoGenomics Reports 122% Revenue Growth to $60.5 Million and 11% Reduction in Average Cost per Test in the Fourth Quarter of 2016
NEOGENOMICS (NASDAQ: NEO) Delayed: 19.91 --0 (-0%)
Previous Close $19.91    52 Week High $9.54 
Open $19.91    52 Week Low $5.49 
Day High $19.91    P/E 497.75 
Day Low $19.91    EPS $0.04 
Volume 15